Antidiabetics Market size is evaluated at USD 106.9 billion in 2024 and is likely to cross USD 294.1 billion by the end of 2037, registering more than 8.8% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of antidiabetics is assessed at USD 116.3 Billion.
The increasing cases of diabetes, the rising geriatric population, and ongoing advancements in anti-diabetic drugs are positively influencing the overall antidiabetics market growth. According to the World Health Organization (WHO), diabetes is a chronic metabolic disease that affects the eyes, heart, kidneys, and nerves over time. Type 2 diabetes is most common across the world and particularly affects adults. Type 1 diabetes also known as juvenile diabetes or insulin-dependent diabetes is chronic in nature and can be treated through insulin intakes. As per WHO estimations around 422 million people are living with diabetes globally, and about 1.5 million deaths occur yearly due to diabetes.
The rising adoption of a sedentary lifestyle, hike in obesity cases, and poor eating habits are driving the prevalence of diabetes, ultimately augmenting the sales of antidiabetic drugs. According to World Obesity Atlas 2023, more than half of the global population is likely to become obese in the next 12 years if proper treatment and support are not provided. According to the National Center for Biotechnology Information (NCBI), excess amount of body fat is one of the causes of type 2 diabetes.
Growth Drivers:
Challenges:
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.8% |
|
Base Year Market Size (2024) |
USD 106.9 billion |
|
Forecast Year Market Size (2037) |
USD 294.1 billion |
|
Regional Scope |
|
Product (Insulin, Drug Class)
Insulin segment is predicted to capture antidiabetics market share of over 53.5% by 2037, owing to its effective results in diabetic care. Insulin is one of the most preferred therapies for diabetes control and offers effective results in type 1 patients. According to the National Institute of Diabetes and Digestive and Kidney Diseases, type 1 diabetic patients are suggested to take insulin as their bodies do not make it. The ways to take insulin are through insulin pens, insulin pumps, and syringes, automated insulin delivery system or artificial pancreas is also an option to take insulin for some patients.
Patient Population (Pediatric, Adults, Geriatric)
The geriatric segment in antidiabetics market is expected to hold a dominant revenue share through the forecasted period. Senior people are more prone to chronic disorders such as diabetes and often require antidiabetics such as insulin to control and maintain their glucose levels. Obesity, lack of proper diet, and a sedentary lifestyle are prevalent among the older population, which contributes to a high risk of diabetes leading to growing sales of antidiabetics. For instance, according to the Endocrine Society report, 33% of diabetic patients are aged 65 or older, and have a high risk of developing diabetes-related issues such as kidney failure, heart disorder, and hypoglycemia.
Our in-depth analysis of the antidiabetics market includes the following segments:
|
Product |
|
|
Patient Population |
|
|
Route of Administration |
|
North America Market Forecast
North America in antidiabetics market is likely to dominate around 42.5% revenue share by the end of 2037. The presence of cutting-edge diabetic research and treatment organizations such as the American Diabetes Association, the implementation of favorable reimbursement policies by respective governments, and the production of novel anti-diabetic drugs by key market players are some of the factors driving the market growth in North America.
The U.S. antidiabetics stood at USD 33 billion in 2024 and is expected to expand at a CAGR of 8.9% from 2024 to 2034. The increasing prevalence of diabetes and the strong presence of antidiabetic drug manufacturers are pushing the U.S. market growth. For instance, in January 2023, Eli Lilly and Company announced the expansion of their incretin products (that treat diabetes) manufacturing facility in North Carolina.
Canada is also an opportunistic antidiabetic market producer owing to the high demand for next-gen treatment options. According to Diabetes Canada, around 30% of the population in the country is living with diabetes. Swiftly increasing cases of diabetes and advancements in healthcare facilities are positively influencing the sales of diabetic drugs in the country.
APAC Market Statistics
Asia Pacific is estimated to be a fast-growing antidiabetics market owing to the dramatically increasing cases of diabetics in India, China, and Japan. According to a report published by the Indian Council of Medical Research in 2023, around 100 million people in India are having diabetes.
India is experiencing a hike in diabetes cases and to overcome this issue government is conducting several awareness programs. Through a press release, in December 2022, the Department of Health & Family Welfare, Government of India announced that they are offering financial and technical support to diabetic patients through initiatives such as ‘Pradhan Mantri Bhartiya Janaushadhi Pariyojana’ (PMBJP) and Free Drugs Service Initiative of NHM. These schemes offer subsidized essential generic medicines for diabetes patients in India. antidiabetics market players in India are offering cost-effective and generic forms of diabetes medication, as the majority of families in the country belong to the middle-class population group. For instance, in January 2024, Lupin Limited announced the production of generic Dapagliflozin and Saxagliptin tablets for the treatment of type 2 diabetes in its Pithampur facility in India. Similarly, in August 2022, Cadila Pharmaceuticals announced the launch of generic versions of sitagliptin under the brand names Jankey & Sitenali in India to control type 2 diabetes.
Key players in the antidiabetics market are employing several organic and inorganic strategies such as new product launches, collaborations, partnerships, mergers, and regional expansion to increase their market reach and profit shares. Industry giants are entering into partnership strategies with other players to boost technological innovations and develop advanced solutions.
Some of the key players include
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?